KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma
Status:
Not yet recruiting
Trial end date:
2023-06-15
Target enrollment:
Participant gender:
Summary
This study is an open, multi-center clinical trial, the purpose is to study the safety and
preliminary efficacy of KN046 combined with Ningatinib in subjects with advanced
hepatocellular carcinoma.